The FDA has granted full approval for Laverdia, the first oral at-home treatment for canine lymphoma, developed by Anivive Lifesciences and distributed by Dechra. As an XPO1 inhibitor, it represents a new class of veterinary cancer treatment, and it's designed to be administered by pet owners at home rather than in a clinic.
The significance goes beyond this one drug. It's a signal that the future of some veterinary treatment is outpatient and at-home by design, not a workaround for when a clinic visit isn't feasible.
Care Is Moving Outside the Clinic on Multiple Fronts
Laverdia isn't an isolated development. Access to veterinary care has been under real pressure on the cost side, and states including Rhode Island have begun loosening telehealth rules that previously required an in-person visit before virtual care could be used.
The shift is broader than any single law or drug. Chewy Health published a free 2026 CE calendar covering both medical topics and non-medical skills, explicitly designed for distributed, digitally enabled veterinary teams. The profession is slowly but steadily building infrastructure for care that doesn't require every touchpoint to happen in a clinic. Rhode Island's telehealth loosening is one piece of a wider access story we've covered in Cost Keeps Getting Between Pet Owners and the Care They Want to Give, which looks at what else is changing state by state.
At-home and outpatient models are quickly becoming standard infrastructure rather than a stopgap. New at-home treatment options like Laverdia change what compliance looks like for owners managing a chronic or serious diagnosis, which means practices should be ready to support at-home dosing with clear monitoring guidance rather than treating it as an edge case.
Telehealth expansion and CE investment both point the same direction: cost, distance, and clinic-based stress are being chipped away at from several angles at once rather than by any single fix. The practices that get ahead of this are the ones building the at-home monitoring and follow-up workflow now, before a client asks whether there's an alternative to the exam room.